• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

Baricitinib

Peptic ulcer bleeding is certainly a significant medical problem with significant

December 20, 2018 by Katherine Lewis Leave a Comment

Peptic ulcer bleeding is certainly a significant medical problem with significant morbidity and mortality. 80 mg intravenous bolus accompanied by 8 mg/h for 3 d as well as the re-bleeding prices were also lower in the PPI group in comparison using the placebo group (Time 3: 5/120 24/120 0.001; Time 30: 8/120 27/120, 0.001). Alternatively, … [Read more…]

Posted in: Blogging Tagged: Baricitinib, COG3

Peroxisome proliferator-activated receptor (PPAR-has helped to unravel the molecular basis of

October 30, 2018 by Katherine Lewis Leave a Comment

Peroxisome proliferator-activated receptor (PPAR-has helped to unravel the molecular basis of its function, including molecular details regarding ligand binding, conformational changes from the receptor, and cofactor binding, resulting in the emergence of the idea of selective PPAR-modulators (SPPARbelongs towards the nuclear receptor superfamily and it is a member from the NR1C subgroup which includes PPAR-and … [Read more…]

Posted in: Blogging Tagged: Baricitinib, CD7

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by